Loading...
Chemical structure of Kuguaglycoside C

GF10422

Kuguaglycoside C

Also known as (3S,7S,8S,9R,10R,13R,14S,17R)-3-hydroxy-4,4,13,14-tetramethyl-17-[(2R,4E)-6-methylhepta-4,6-dien-2-yl]-7-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-9-carbaldehyde

Kuguaglycoside C (catalogue number GF10422) is a research-grade chemical available from LABO Scientific in Israel, CAS registry number 1041631-93-9. Molecular formula C36H56O8, molecular weight 616.83. IUPAC name: (3S,7S,8S,9R,10R,13R,14S,17R)-3-hydroxy-4,4,13,14-tetramethyl-17-[(2R,4E)-6-methylhepta-4,6-dien-2-yl]-7-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-9-carbaldehyde. Supplied as 5mg at ₪2,855.24; the final price is confirmed on your quote, and the lot certificate of analysis and safety data sheet are emailed with your order confirmation.

ChemicalCAS1041631-93-9MW616.83FormulaC36H56O8
CAS number
1041631-93-9
Molecular weight
616.83
Formula
C36H56O8
InChIKey
OMBHCPPEZFBPJG-ZBAJYRRDSA-N
Catalogue number
GF10422
Brand
GLPBIO
Computed properties PubChem CID 101447827 · XLogP 4.8 · TPSA 137 Ų · H-bond donors 5
XLogP
4.8
TPSA
137 Ų
H-bond donors
5
H-bond acceptors
8
Rotatable bonds
8
Heavy atoms
44

SMILES C[C@H](C/C=C/C(=C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@@]3([C@H]2[C@H](C=C4[C@H]3CC[C@@H](C4(C)C)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C=O)C)C

Computed descriptors from PubChem (CID 101447827), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.